Genomic algorithms
Total Trials
11
As Lead Sponsor
8
As Collaborator
3
Total Enrollment
2,060
NCT01092559
Pilot Study Evaluating the Safety and Performance of the GeNO NITROsyl Delivery System for Inhaled Nitric Oxide
Phase: Phase 2
Role: Lead Sponsor
Start: Oct 31, 2010
Completion: Jul 31, 2011
NCT01265888
Study in Subjects With PAH and PH Secondary to IPF Using Inhaled GeNOsyl.
Start: Mar 31, 2011
Completion: Sep 30, 2016
NCT01426516
Pharmacogenomics for Antidepressant Guidance and Education 1 (PAGE-1_AG1)
Phase: N/A
Start: Sep 30, 2011
Completion: Jun 30, 2014
NCT01507155
An Open Label Study of Clinical Utility and Patient Outcomes of the Genecept Assay
Start: Apr 30, 2013
Completion: May 31, 2014
NCT02566057
Prospective Pharmacogenetic Testing and Clinical Outcomes in Patients With Early-Phase Psychosis
Role: Collaborator
Start: Jul 10, 2014
Completion: Dec 31, 2017
NCT01438242
An Open Label Study of the Genecept™ Assay in Treatment Resistant Depression
Start: Jan 31, 2015
Completion: Jan 31, 2016
NCT02436512
Study to Assess Acute Vasodilation Response of Inhaled Nitric Oxide
Phase: Phase 3
Start: Jun 30, 2015
Completion: Aug 31, 2015
NCT02634177
Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD
Start: Jan 31, 2016
Completion: Jul 25, 2017
NCT03113890
McLean and Genomind Prospective Study
Start: Sep 22, 2017
Completion: Jul 31, 2020
NCT03468309
Medication Optimization Using Pharmacogenetic Testing and the G-DIG to Reduce Polypharmacy in a Mental Health Population
Start: Jan 1, 2018
Completion: Apr 17, 2024
NCT05294419
The Healthcare Evaluation of Absolute Risk Testing Study
Start: Nov 4, 2021
Completion: Sep 30, 2022
Loading map...